Latest News about GSK
Recent news which mentions GSK
   3 Bill Gates Stocks to Buy for Billionaire-Like Returns
   
  
  October 27, 2023
  Tags
   VIR
   MXF
   NASDAQ:MSFT,NYSE:BRK/A,NYSE:BRK/B,NASDAQ:SDGR,NYSE:KOF,NYSE:KO,NYSE:MXF,NYSE:FMX,NASDAQ:VIR,NYSE:GSK
  
  From InvestorPlace
 
   3 Deeply Undervalued Growth Stocks
   
  
  
  October 27, 2023
  From InvestorPlace
 
   Bank Of America, Mastercard, NRA And Others Are Lobbying For Cannabis Banking Reform — Who Knew?
   
  
  
  October 22, 2023
  From Benzinga
 
   Pfizer gets FDA green light for new shot that can streamline teenagers’ vaccinations
   
  
  
  October 20, 2023
  From MarketWatch
 
   Startup Cerebras stands out in the high-risk AI chip arena: ‘No one has built a chip this big’
   
  
  
  October 11, 2023
  From MarketWatch
 From Benzinga
 
   China-Based Zhifei Biological Partners With GSK To Expand Shingrix Vaccine Access Across China Via £2.5B Deal
   
  October 09, 2023
  Tickers 
   GSK
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   7 ‘Smart Money’ Stocks Set to Explode Higher
   
  
  
  September 30, 2023
  From InvestorPlace
 
   Moderna's Shares Could Take Off if These 2 Things Happen
   
  
  
  September 30, 2023
  From Motley Fool
 
   Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
   
  
  
  September 27, 2023
  From Benzinga
 
   Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
   
  
  
  September 26, 2023
  From Benzinga
 
   Why Are Antifungal Focused Scynexis Stock Plunging Today?
   
  
  
  September 25, 2023
  From Benzinga
 
   CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants
   
  
  
  September 25, 2023
  From Benzinga
 From Benzinga
 
   European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug
   
  
  
  September 19, 2023
  From Benzinga
 
   Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
   
  
  
  September 18, 2023
  From Benzinga
 
   One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing
   
  
  
  September 18, 2023
  From Benzinga
 
   Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal
   
  September 18, 2023
  Tickers 
   GSK
  
  
  From Benzinga
 
   Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
   
  
  
  September 14, 2023
  From Benzinga
 
   Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
   
  
  
  September 13, 2023
  From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
